» Articles » PMID: 14517272

An Early CD4+ T Cell-dependent Immunoglobulin A Response to Influenza Infection in the Absence of Key Cognate T-B Interactions

Overview
Journal J Exp Med
Date 2003 Oct 1
PMID 14517272
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Contact-mediated interactions between CD4+ T cells and B cells are considered crucial for T cell-dependent B cell responses. To investigate the ability of activated CD4+ T cells to drive in vivo B cell responses in the absence of key cognate T-B interactions, we constructed radiation bone marrow chimeras in which CD4+ T cells would be activated by wild-type (WT) dendritic cells, but would interact with B cells that lacked expression of either major histocompatibility complex class II (MHC II) or CD40. B cell responses were assessed after influenza virus infection of the respiratory tract, which elicits a vigorous, CD4+ T cell-dependent antibody response in WT mice. The influenza-specific antibody response was strongly reduced in MHC II knockout and CD40 knockout mice. MHC II-deficient and CD40-deficient B cells in the chimera environment also produced little virus-specific immunoglobulin (Ig)M and IgG, but generated a strong virus-specific IgA response with virus-neutralizing activity. The IgA response was entirely influenza specific, in contrast to the IgG2a response, which had a substantial nonvirus-specific component. Our study demonstrates a CD4+ T cell-dependent, antiviral IgA response that is generated in the absence of B cell signaling via MHC II or CD40, and is restricted exclusively to virus-specific B cells.

Citing Articles

Distinct Requirements for CD4 T Cell Help for Immune Responses Induced by mRNA and Adenovirus-Vector SARS-CoV-2 Vaccines.

Yong L, Hutchings C, Barnes E, Klenerman P, Provine N Eur J Immunol. 2024; 55(1):e202451142.

PMID: 39604225 PMC: 11739681. DOI: 10.1002/eji.202451142.


CD4 T cells re-wire granuloma cellularity and regulatory networks to promote immunomodulation following Mtb reinfection.

Bromley J, Ganchua S, Nyquist S, Maiello P, Chao M, Jacob Borish H Immunity. 2024; 57(10):2380-2398.e6.

PMID: 39214090 PMC: 11466276. DOI: 10.1016/j.immuni.2024.08.002.


CD4 T cells are homeostatic regulators during reinfection.

Bromley J, Ganchua S, Nyquist S, Maiello P, Chao M, Jacob Borish H bioRxiv. 2024; .

PMID: 38187598 PMC: 10769325. DOI: 10.1101/2023.12.20.572669.


The role of CD4 T cells in tumor and chronic viral immune responses.

Xie L, Fang J, Yu J, Zhang W, He Z, Ye L MedComm (2020). 2023; 4(5):e390.

PMID: 37829505 PMC: 10565399. DOI: 10.1002/mco2.390.


Narrative review on century of respiratory pandemics from Spanish flu to COVID-19 and impact of nanotechnology on COVID-19 diagnosis and immune system boosting.

Elkhatib W, Abdelkareem S, Khalaf W, Shahin M, Elfadil D, Alhazmi A Virol J. 2022; 19(1):167.

PMID: 36280866 PMC: 9589879. DOI: 10.1186/s12985-022-01902-2.


References
1.
Kitamura D, Roes J, Kuhn R, Rajewsky K . A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature. 1991; 350(6317):423-6. DOI: 10.1038/350423a0. View

2.
Jenkins M, Khoruts A, Ingulli E, Mueller D, McSorley S, Reinhardt R . In vivo activation of antigen-specific CD4 T cells. Annu Rev Immunol. 2001; 19:23-45. DOI: 10.1146/annurev.immunol.19.1.23. View

3.
Kantor A, Stall A, Adams S, Herzenberg L . Adoptive transfer of murine B-cell lineages. Ann N Y Acad Sci. 1992; 651:168-9. DOI: 10.1111/j.1749-6632.1992.tb24610.x. View

4.
Caton A, GERHARD W . The diversity of the CD4+ T cell response in influenza. Semin Immunol. 1992; 4(2):85-90. View

5.
Mombaerts P, Clarke A, Rudnicki M, Iacomini J, Itohara S, Lafaille J . Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages. Nature. 1992; 360(6401):225-31. DOI: 10.1038/360225a0. View